Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Brigatinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113024454A reveals a novel synthesis for brigatinib intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.